Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110615811A enables high-purity chiral ligand synthesis via crystallization method eliminating column chromatography thus reducing manufacturing costs and improving supply chain reliability.
Novel axial chiral phosphine-ene ligand enables high-yield asymmetric allylation with mild conditions, reducing manufacturing costs and lead times for fine chemicals.
Discover how this novel chiral catalyst enables 99% ee synthesis with 90% yield, reducing R&D costs and supply chain risks for oncology drug development.
Solve low-yield C-H activation challenges with 94% yield & 92% ee. Scale to 100MT/yr with no byproducts. Contact for COA/MSDS.
Solve enantioselectivity challenges in asymmetric hydrogenation with tunable bisphosphine ligands. Achieve 92-99% ee, recyclable catalysts, and simplified synthesis for cost-effective API production.
Discover how novel axial chiral phosphine-ene ligands enable high-yield, enantioselective allyl substitutions with simplified manufacturing for pharma R&D and production.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.
97% ee, >95% yield, low-cost industrial production of chiral alpha-hydroxy-beta-keto esters for agrochemicals. Solve supply chain risks with scalable zirconium catalysis.
Solve chiral ligand supply chain risks with this metal-free synthesis. 86% yield, no resolution needed. Contact for custom production.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee, and water-tolerant processes reduce production costs for pharma R&D and manufacturing.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.
Eliminate chiral column costs with novel crystallization-based resolution. Achieve >99% ee and 76-78% yield for 6,6'-dihydroxy-5,5'-bisquinoline. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.
Solve low-yield issues in 2-benzamido-3-aryl acrylate production with this 80%+ yield one-step method. Reduce costs and time for chiral ligand evaluation and API synthesis.
Discover how visible light-driven catalysis enables 80-90% yields with 90-99% ee for chiral alpha-unnatural amino acids, eliminating costly chiral resolution steps in drug development.
Discover how visible light-driven copper catalysis eliminates chiral resolution steps, achieves 90-99% ee, and reduces production costs for non-natural amino acid derivatives in pharmaceutical synthesis.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.
Discover a scalable chiral ligand synthesis method with 80%+ yield, eliminating column chromatography to cut costs and environmental impact. Ideal for API manufacturing.
Struggling with high-temperature, toxic solvent processes for 9-acetoxy-9,10-dihydrophenanthrene? Discover emerging iridium photocatalysis for green, high-yield synthesis. Find reliable suppliers now.